{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T12:18:52Z","timestamp":1781266732992,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ejso.2022.02.002","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T11:49:57Z","timestamp":1643888997000},"page":"1614-1618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Early postoperative intraperitoneal chemotherapy (EPIC) following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in 632 patients with pseudomyxoma peritonei of appendiceal origin: A single institution experience"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1589-1040","authenticated-orcid":false,"given":"Xavier","family":"Fung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4844-3911","authenticated-orcid":false,"given":"I.Chuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandiah","family":"Chandrakumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Cecil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Dayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0128-0350","authenticated-orcid":false,"given":"Alexios","family":"Tzivanakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8184-2511","authenticated-orcid":false,"given":"Brendan","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faheez","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejso.2022.02.002_bib1","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/DCR.0000000000001682","article-title":"Mode of presentation in 1070 patients with perforated epithelial appendiceal tumors, predominantly with pseudomyxoma peritonei","volume":"63","author":"Sharif","year":"2020","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"10.1016\/j.ejso.2022.02.002_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1245\/s10434-020-08655-8","article-title":"Estimating the prevalence of pseudomyxoma peritonei in Europe using a novel statistical method","volume":"28","author":"Patrick-Brown","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.02.002_bib3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00000658-199402000-00002","article-title":"Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach","volume":"219","author":"Gough","year":"1994","journal-title":"Ann Surg"},{"issue":"20","key":"10.1016\/j.ejso.2022.02.002_bib4","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2022.02.002_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/DCR.0b013e318202f026","article-title":"Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin","volume":"54","author":"Youssef","year":"2011","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"10.1016\/j.ejso.2022.02.002_bib6","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejso.2010.01.006","article-title":"Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy","volume":"36","author":"Elias","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2022.02.002_bib7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ejso.2016.03.017","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours","volume":"42","author":"Ansari","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2022.02.002_bib8","first-page":"F433","article-title":"The transport barrier in intraperitoneal therapy","volume":"288","author":"Flessner","year":"2005","journal-title":"Am J Physiol"},{"issue":"7","key":"10.1016\/j.ejso.2022.02.002_bib9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/jnci\/89.7.480","article-title":"Pharmacokinetic problems in peritoneal drug administrattion: tissue penetration and surface exposure","volume":"89","author":"Dedrick","year":"1997","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.ejso.2022.02.002_bib10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1245\/ASO.2003.08.006","article-title":"Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia","volume":"10","author":"Mohamed","year":"2003","journal-title":"Ann Surg Oncol"},{"issue":"18","key":"10.1016\/j.ejso.2022.02.002_bib11","first-page":"5790","article-title":"Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies","volume":"50","author":"Sugarbaker","year":"1990","journal-title":"Cancer Res"},{"issue":"115","key":"10.1016\/j.ejso.2022.02.002_bib12","first-page":"705","article-title":"The influence of tumor cell entrapment phenomenon on the natural history of Pseudomyxoma peritonei syndrome","volume":"59","author":"Spiliotis","year":"2012","journal-title":"Hepato-Gastroenterology"},{"issue":"26","key":"10.1016\/j.ejso.2022.02.002_bib13","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1200\/JCO.2015.61.4776","article-title":"Use and effectiveness of intraperitoneal chemotherapy for treatment of ovarian cancer","volume":"33","author":"Wright","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2022.02.002_bib14","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.ejso.2018.06.023","article-title":"Single centre guidelines for radiological follow-up based on 775 patients treated by cytoreductive surgery and HIPEC for appendiceal pseudomyxoma peritonei","volume":"44","author":"Govaerts","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2022.02.002_bib15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/jso.23276","article-title":"HIPEC\u00a0+ EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy","volume":"107","author":"McConnell","year":"2013","journal-title":"J\u00a0Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2022.02.002_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/02656736.2015.1135485","article-title":"Does early post-operative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference?","volume":"32","author":"Tan","year":"2016","journal-title":"Int J Hyperther"},{"key":"10.1016\/j.ejso.2022.02.002_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.02.002_bib18","series-title":"Intraperitoneal chemotherapy and cytoreductive surgery: manual for physicians and nurses","author":"Sugarbaker","year":"1998"},{"key":"10.1016\/j.ejso.2022.02.002_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The clavien-dindo classification of surgical complications five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejso.2022.02.002_bib20","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ejso.2014.08.476","article-title":"Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours","volume":"41","author":"Lord","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.02.002_bib21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1245\/s10434-006-9174-x","article-title":"Progression of pseudomyxoma peritonei after combined modality treatment: management and outcome","volume":"14","author":"Smeenk","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2022.02.002_bib22","first-page":"414","article-title":"Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer","volume":"98","author":"Sugarbaker","year":"1985","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.ejso.2022.02.002_bib23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejso.2020.08.026","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with or without early post-operative intraperitoneal chemotherapy for appendix neoplasms with peritoneal metastases: a propensity score analysis","volume":"47","author":"Soucisse","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2022.02.002_bib24","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/codi.12975","article-title":"The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy","volume":"17","author":"Moran","year":"2015","journal-title":"Colorectal Dis"},{"issue":"13","key":"10.1016\/j.ejso.2022.02.002_bib25","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/bjs.9674","article-title":"Peritoneal Surface Oncology Group International (PSOGI). Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei","volume":"101","author":"Kusamura","year":"2014","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.ejso.2022.02.002_bib26","doi-asserted-by":"crossref","first-page":"20190007","DOI":"10.1515\/pp-2019-0007","article-title":"Early postoperative intraperitoneal chemotherapy for lower gastrointestinal neoplasms with peritoneal metastasis: a systematic review and critical analysis","volume":"4","author":"Soucisse","year":"2019","journal-title":"Pleura Peritoneum"},{"issue":"1","key":"10.1016\/j.ejso.2022.02.002_bib27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1245\/s10434-016-5529-0","article-title":"Early postoperative intraperitoneal chemotherapy for low-grade Appendiceal mucinous neoplasms with pseudomyxoma peritonei: is it beneficial?","volume":"24","author":"Huang","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.02.002_bib28","doi-asserted-by":"crossref","unstructured":"Rossi AJ, Annals of surgical oncology . https:\/\/doi.org\/10.1245\/s10434-021-10110-1.","DOI":"10.1245\/s10434-021-10110-1"},{"issue":"2","key":"10.1016\/j.ejso.2022.02.002_bib29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2022.02.002_bib30","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.21037\/jgo-2020-15","article-title":"The PRODIGE 7 randomized trial has 4 design flaws and 4 pharmacologic flaws and cannot be used to discredit other HIPEC regimens","volume":"12","author":"Sugarbaker","year":"2021","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.ejso.2022.02.002_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/codi.15596","article-title":"Randomized controlled trials in surgical resection of colorectal peritoneal metastases: disentangling negativity in PRODIGE 7 and PROPHYLOCHIP","author":"Moran","year":"2021","journal-title":"Colorectal Dis"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322000750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322000750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:43:34Z","timestamp":1760060614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798322000750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0748798322000750"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2022.02.002","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early postoperative intraperitoneal chemotherapy (EPIC) following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in 632 patients with pseudomyxoma peritonei of appendiceal origin: A single institution experience","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2022.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2022 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}